Cargando…

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

PURPOSE: Characterization of virosomes, in late stage preclinical development as vaccines for Respiratory Syncytial Virus (RSV), with a membrane-incorporated synthetic monophosphoryl lipid A, 3D-PHAD® adjuvant. METHODS: Virosomes were initially formed by contacting a lipid film containing 3D-PHAD® w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lederhofer, J., van Lent, J., Bhoelan, F., Karneva, Z., de Haan, A., Wilschut, J.C., Stegmann, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061504/ https://www.ncbi.nlm.nih.gov/pubmed/29971500 http://dx.doi.org/10.1007/s11095-018-2453-y

Ejemplares similares

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
por: Kamphuis, Tobias, et al.
Publicado: (2012)

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats
por: Kamphuis, Tobias, et al.
Publicado: (2013)

Enhanced HPV16 E6/E7(+) tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
por: Stegmann, Toon, et al.
Publicado: (2023)

Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses
por: Shafique, Muhammad, et al.
Publicado: (2013)

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
por: Tamborrini, Marco, et al.
Publicado: (2011)

Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
por: Fernandes, Bárbara, et al.
Publicado: (2022)

Phasin interactome reveals the interplay of PhaF with the polyhydroxyalkanoate transcriptional regulatory protein PhaD in Pseudomonas putida
por: Tarazona, Natalia A., et al.
Publicado: (2020)

New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes
por: Amacker, Mario, et al.
Publicado: (2020)

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015)

Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
por: Soema, Peter C., et al.
Publicado: (2014)

Virosome: An engineered virus for vaccine delivery
por: Ali, Hasan, et al.
Publicado: (2023)

A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge
por: Koopman, Gerrit, et al.
Publicado: (2023)

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice
por: Ebensen, Thomas, et al.
Publicado: (2017)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Matrix‐M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model
por: Pedersen, Gabriel, et al.
Publicado: (2011)

Virosome Presents Multimodel Cancer Therapy without Viral Replication
por: Saga, Kotaro, et al.
Publicado: (2013)

A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers
por: Genton, Blaise, et al.
Publicado: (2007)

Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models
por: Tamborrini, Marco, et al.
Publicado: (2020)

In silico comparative structural and compositional analysis of glycoproteins of RSV to study the nature of stability and transmissibility of RSV A
por: Mitra, Debanjan, et al.
Publicado: (2022)

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022)

Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination
por: Assink, M.D.M., et al.
Publicado: (2009)

Reconstruction of H(3)N(2) influenza virus based virosome in-vitro
por: Abdoli, Asghar, et al.
Publicado: (2013)

Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
por: Fonseca, Francisco Noé, et al.
Publicado: (2023)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge
por: Cox, Freek, et al.
Publicado: (2015)

Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy
por: Liu, Qiushi, et al.
Publicado: (2015)

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
por: Cech, Patrick Georges, et al.
Publicado: (2011)

Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells
por: Cox, Freek, et al.
Publicado: (2015)

Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine
por: Alicino, Cristiano, et al.
Publicado: (2014)

Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan
por: Rasool, Muhammad Hidayat, et al.
Publicado: (2021)

A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs
por: Haach, Vanessa, et al.
Publicado: (2023)

Construction of influenza virosome from influenza A H1N1 PR8
por: Noori, Mehri, et al.
Publicado: (2011)

2657. Investigation of Respiratory Syncytial Virus (RSV) Stability in Nasal Aspirate Collected from RSV Infected Patients
por: Yamamoto, Atsuko, et al.
Publicado: (2023)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
por: Grosz, Drew D, et al.
Publicado: (2014)

Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
por: Thompson, Fiona M., et al.
Publicado: (2008)

Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
por: Asadi, Khatereh, et al.
Publicado: (2021)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age
por: Jans, Jop, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4rjtu3lf50skq2g6amqcd56msl